Results 101 to 110 of about 26,442 (182)

Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Primary pyruvate dehydrogenase complex deficiency (PDCD) comprises a group of monogenic disorders caused by pathogenic variants in genes encoding subunits of, or regulatory components affecting, the pyruvate dehydrogenase complex. The clinical phenotype spans a broad continuum, ranging from early onset congenital lactic acidosis to infantile ...
Nandaki Keshavan   +23 more
wiley   +1 more source

Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough

open access: yesThe Laryngoscope, Volume 136, Issue 11, Page 4938-4944, November 2026.
The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen   +3 more
wiley   +1 more source

Persistent Coronavirus Disease 2019 (COVID‐19) in Patients With Malignant Lymphoma Treated With Anti‐CD20 Antibodies Who Responded to Ensitrelvir: A Report of Three Cases

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
Patients with malignant lymphoma receiving anti‐CD20 antibody therapy are at high risk of persistent coronavirus disease 2019 (COVID‐19). We report three cases of persistent COVID‐19 in patients with follicular lymphoma who responded clinically after switching to ensitrelvir following the failure of remdesivir‐based treatment. Switching to an antiviral
Mika Horie   +12 more
wiley   +1 more source

Refractory Chronic Cough at the Crossroads

open access: yesArchivos de Bronconeumología (English Edition), 2020
openaire   +2 more sources

Spontaneous Reduction in Mitral Valve Regurgitation in Three Dogs With Severe Myxomatous Mitral Valve Disease: An Unusual Case Report

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
In dogs with MMVD, severe valvular degeneration with chordae tendineae rupture is generally associated with a poor prognosis despite medical management. These three cases demonstrate spontaneous reduction in mitral regurgitation accompanied by decreased coaptation gap, reduced regurgitant volume, reverse cardiac remodelling, discontinuation of ...
Hyo‐Seung Nam, Yein Oh
wiley   +1 more source

Presumptive necrotising fasciitis with concurrent pyothorax in a 9‐month‐old Great Dane

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract A 9‐month‐old, entire, male Great Dane presented with rapid multi‐limb swelling, pyrexia and diarrhea following initial treatment for presumed gastroenteritis. Diagnostic evaluation revealed septic pleuropneumonia concurrent with rapidly progressive soft tissue infection affecting three limbs.
Christopher Ponticello
wiley   +1 more source

Nasal Obstruction Is Reduced 5–7 Years After Radiofrequency Turbinate Reduction: Results From a Retrospective Observational Cohort Study

open access: yesClinical Otolaryngology, Volume 51, Issue 6, Page 914-922, November 2026.
ABSTRACT Introduction Nasal obstruction, often caused by structural and inflammatory conditions, is prevalent and significantly impacts health‐related quality of life. Radiofrequency Turbinate Reduction (RFTR) is a widely employed treatment for inferior turbinate hypertrophy, yet evidence of its long‐term effectiveness remains limited. This study aimed
Veronica Ahlund   +3 more
wiley   +1 more source

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

open access: yesMycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy